Investing Experience -
Risk Profile -
Followers
0
Following
0
Blog Posts
0
Threads
1,560
Blogs
Threads
Portfolio
Follower
Following
Summary
Total comments
1,560
Past 30 days
0
Past 7 days
0
Today
0
User Comments
Stock
Stock
2020-07-23 19:45 | Report Abuse
Please dont cry father cry mother it will be too late hahahakekekeke
Its very obvious this stock is manipulated/speculated by operator/syndicate n still want to denied hahahah
Stock
2020-07-23 19:44 | Report Abuse
Please dont cry father cry mother it will be too late hahahakekekeke
Its very obvious this stock is manipulated/speculated by operator/syndicate n still want to denied hahahah
Stock
2020-07-23 19:42 | Report Abuse
Vaccine found ? This link will give u more info https://youtu.be/OSCuOsaOE48
Aids , H1N1 , SARS , Malaria , dengue and many more viruses alreday few decades n no vaccine found yet .
Do u think Convid 19 vaccine can easily be invented such a short time. hahaha
The old viruses still cannot Kow Tim n want to solve this mysterious convid 19 viru
Stock
2020-07-23 19:42 | Report Abuse
Vaccine found ? This link will give u more info https://youtu.be/OSCuOsaOE48
Aids , H1N1 , SARS , Malaria , dengue and many more viruses alreday few decades n no vaccine found yet .
Do u think Convid 19 vaccine can easily be invented such a short time. hahaha
The old viruses still cannot Kow Tim n want to solve this mysterious convid 19 viru
Stock
2020-07-23 19:40 | Report Abuse
Deputy Minister: Years before precise vaccine is made publicly available for Covid-19
NATION
Wednesday, 22 Jul 2020
Stock
2020-07-23 19:40 | Report Abuse
Deputy Minister: Years before precise vaccine is made publicly available for Covid-19
NATION
Wednesday, 22 Jul 2020
Stock
2020-07-23 19:38 | Report Abuse
Talk is cheap n free (no charge)EPF keep buy in.?????????????????????????????????
Tuesday, 21 Jul 2020
5:05PM DPHARMA EMPLOYEES PROVIDENT FUND BOARD (1,471,300 units Disposed)
pang72 Dpharma more liquidity.
Profit is constant. 50% more capacity by 2021.
EPF keep buy in.
Management has visibility for future plan.
No bad historical of government contract termination.
Stock
2020-07-23 19:37 | Report Abuse
Talk is cheap n free (no charge)EPF keep buy in.?????????????????????????????????
Tuesday, 21 Jul 2020
5:05PM DPHARMA EMPLOYEES PROVIDENT FUND BOARD (1,471,300 units Disposed)
pang72 Dpharma more liquidity.
Profit is constant. 50% more capacity by 2021.
EPF keep buy in.
Management has visibility for future plan.
No bad historical of government contract termination.
Margin better
Stock
2020-07-22 21:40 | Report Abuse
Tuesday, 21 Jul 2020
5:05PM DPHARMA EMPLOYEES PROVIDENT FUND BOARD (1,471,300 units Disposed)
Stock
2020-07-22 21:40 | Report Abuse
Tuesday, 21 Jul 2020
5:05PM DPHARMA EMPLOYEES PROVIDENT FUND BOARD (1,471,300 units Disposed)
Stock
2020-07-22 21:40 | Report Abuse
Tuesday, 21 Jul 2020
5:05PM DPHARMA EMPLOYEES PROVIDENT FUND BOARD (1,471,300 units Disposed)
Stock
2020-07-22 21:39 | Report Abuse
Tuesday, 21 Jul 2020
5:05PM DPHARMA EMPLOYEES PROVIDENT FUND BOARD (1,471,300 units Disposed)
Stock
2020-07-22 19:47 | Report Abuse
Walao target alrd limit up 2 days continuous , what if confirm 100 times limit up ?
dhnn81 Aramco, agreed with that statement from Deputy Health Minister. Notice the word "precise".
He was referring to 3rd or 4th generation of the vaccine. It is normal that vaccine is continuously improved as they collected more data and results through the use of the vaccine. At this current stage, I think Pharma/DPharma roles are to target the first generation of the vaccine.
22/07/2020 7:35 PM
Stock
2020-07-22 19:40 | Report Abuse
Just wake up from coma kah ? or still dreaming in Wonderland or maybe retarded ?
southern tyco: which stock got fundamental at current CHINA VIRUS?
22/07/2020 4:40 PM
Stock
2020-07-22 19:37 | Report Abuse
Deputy Minister: Years before precise vaccine is made publicly available for Covid-19
NATION
Wednesday, 22 Jul 2020
12:32 PM MYT
stockraider Better sell & switch to Dpharma b4 too late loh...!!
Vaccine will be here very soon mah,,!
Stock
2020-07-22 19:35 | Report Abuse
Deputy Minister: Years before precise vaccine is made publicly available for Covid-19
NATION
Wednesday, 22 Jul 2020
12:32 PM MYT
Stock
2020-07-22 19:31 | Report Abuse
Deputy Minister: Years before precise vaccine is made publicly available for Covid-19
NATION
Wednesday, 22 Jul 2020
12:32 PM MYT
Stock
2020-07-22 19:30 | Report Abuse
Deputy Minister: Years before precise vaccine is made publicly available for Covid-19
NATION
Wednesday, 22 Jul 2020
12:32 PM MYT
Stock
2020-07-22 19:30 | Report Abuse
Deputy Minister: Years before precise vaccine is made publicly available for Covid-19
NATION
Wednesday, 22 Jul 2020
12:32 PM MYT
Stock
2020-07-22 19:29 | Report Abuse
Deputy Minister: Years before precise vaccine is made publicly available for Covid-19
NATION
Wednesday, 22 Jul 2020
12:32 PM MYT
Stock
Stock
2020-07-21 00:18 | Report Abuse
KYY view Author: Koon Yew Yin | Latest post: Mon, 20 Jul 2020, 6:56 PM
Hengyuan: Its price closed at Rm 16.50 yesterday. Its 3rd quarter EPS was 243 sen. Assuming its 4th quarter is the same as its average EPS of the last 3 quarters, its full year EPS will be 324 sen. It is selling at P/E of 5.
You must bear in mind that Hengyuan’s controlling shareholder is a famous China National Petroleum Chemical company called Shandong Hengyuan Petrochemical Company of China.
Can you find another counter with similar quality as Hengyuan which is selling at P/E 5?
In view of the rising prices of crude oil due to demand exceeding supply, Hengyuan should be more profitable in the near future. It should be selling at least at P/E 10. Based on its annual profit of Rm 3.24 it should be selling at Rm 32.40 per share.
Now all readers should know what to do.
Stock
2020-07-21 00:15 | Report Abuse
HighlightsMonitor your investment performance. Create your own Portfolio with charts and advanced reporting functions.
0
Koon Yew Yin's Blog
Author: Koon Yew Yin | Latest post: Mon, 20 Jul 2020, 6:56 PM
An official blog in i3investor to publish sharing by Mr. Koon Yew Yin.
All materials published here are prepared by Mr. Koon Yew Yin
Blog Headlines (by Date) Blog Index
Hengyuan Comparing to Nestle, Dutch Lady, Panasonic and British American Tobacco - Koon Yew Yin
Author: Koon Yew Yin | Publish date: Thu, 28 Dec 2017, 3:06 PM
All investors in the stock market are in a dilemma, I included, when we watch Hengyuan shooting up like a missile. It has gone up from Rm 3 to close at Rm 16.50 within 12 months, an increase of 550%. Almost all investors have not seen another stock which performs like Hengyuan except perhaps Supermax before.
This situation reminds me of Supermax during the HINI epidemic about 7 years ago.
Now we are confronting a new situation.
For example, its price went up Rm 1.10 with 4.93 million shares traded yesterday. As the daily volume traded is a few million shares, obviously there must be a lot more buyers than sellers for the price to go up almost every day.
Who is right and who is wrong?
It is most likely this article will be the useful to all investors. After reading the comparison of Hengyuan with these few counters, which are selling more than Rm 30 per share, you should know what to do.
Nestle: Its share price closed at Rm 99.9 per share yesterday. Its EPS for 3 quarters ending September 2017 was 218 sen. Assuming its 4th quarter is similar to the average EPS of the last 3 quarters its full year EPS will be Rm 2.91. Its P/E ratio will be 34.
Dutch Lady: Its share price closed at Rm 59.80 per share yesterday. Its EPS for 3 quarters was 151 sen. Assuming its 4th quarter EPS as the same as the average of the last 3 quarters, its full year EPS will be Rm 2.00. It is selling at P/E of 30.
Panasonic: Its share price closed at Rm 39 yesterday. Its first half year EPS was 104 sen. Assuming its 2nd half year is similar as its first half year, its full year EPS will be Rm 2.08. It is selling at 19.
BAT: Its share price closed at Rm 36.30 yesterday. Its 3rd quarter EPS was 144 sen. Assuming its 4th quarter EPS will be the same as its average of the last 3 quarters, its full year EPS will be Rm 2.00. It is selling P/E of 18
Hengyuan: Its price closed at Rm 16.50 yesterday. Its 3rd quarter EPS was 243 sen. Assuming its 4th quarter is the same as its average EPS of the last 3 quarters, its full year EPS will be 324 sen. It is selling at P/E of 5.
You must bear in mind that Hengyuan’s controlling shareholder is a famous China National Petroleum Chemical company called Shandong Hengyuan Petrochemical Company of China.
Can you find another counter with similar quality as Hengyuan which is selling at P/E 5?
In view of the rising prices of crude oil due to demand exceeding supply, Hengyuan should be more profitable in the near future. It should be selling at least at P/E 10. Based on its annual profit of Rm 3.24 it should be selling at Rm 32.40 per share.
Now all readers should know what to do.
Stock
Stock
2020-07-21 00:01 | Report Abuse
Yes @degaht KYY is a confuse n greedy old man even reaching 90 years old alrd
Could be dementia old man n cunning too
So sad for him
degaht @Aramco,
that blog written in month of May also he still dont know potential of other gloves and supermax's OBM .
https://koonyewyin.com/2020/05/17/comfort-compares-with-supermax/
" Currently my investment is 70% on Comfort and 30% on Supermax. I am not sure which has the better profit growth prospect in future."
the word: "I am not sure which has the better profit growth prospect in future."
in May also confuse, now in July also confuse.
20/07/2020 11:49 PM
Stock
Stock
2020-07-20 23:39 | Report Abuse
HighlightsPerform research on stocks before trading. Check out the Price Target page.
2
Koon Yew Yin's Blog
Author: Koon Yew Yin | Latest post: Mon, 20 Jul 2020, 6:56 PM
An official blog in i3investor to publish sharing by Mr. Koon Yew Yin.
All materials published here are prepared by Mr. Koon Yew Yin
Blog Headlines (by Date) Blog Index
Comfort compares with Supermax - Koon Yew Yin
Author: Koon Yew Yin | Publish date: Sun, 17 May 2020, 10:12 PM
My old trusted friend Mr Ooi Teik Bee and I had a long discussion about share investing during the Covid 19 pandemic which is affecting almost all the listed companies. We also noticed that the daily traded volumes for Comfort, Supermax, Kossan, Top Glove etc are much larger than before the Covid 19 pandemic. The reason is that all the institutional investors have to sell to cut loss on most of their holdings which they bought before the pandemic to buy glove manufacturers’ shares.
Due to Covid 19 pandemic the demand for gloves far exceeds supply. As a result, the price for gloves continues to go higher and all glove manufacturers will continue to make increasingly more profit which is being reflected on their share prices.
Covid 19 pandemic is affecting the profit of most listed companies with the exception of companies making products for the prevention of the virus infection. Based on this situation, I bought Comfort and Supermax shares recently. Fortunately, the share prices for both have been going up quite rapidly.
Compare annual production of each company with its market capitalization:
Comfort: The last traded price for Comfort is Rm 2.31 and it has 580 million issued shares. Its market capitalization is Rm 1,340 million and its annual production is 5.40 billion gloves. 5.40 billion gloves divided by Rm 1,340 million = 4 sen per glove.
Supermax: The last traded price for Supermax is Rm 3.97 and it has 1,300 million issued shares. Its market capitalization is Rm 5,161 million and its annual production is 27 billion gloves. 27 billion gloves divided by Rm 5,161 million = 5.23 sen per glove.
Compare historical P/E ratio for Supermax:
The above chart shows Supermax’s earning for each quarter for the last 4 quarters totalling 7.99 EPS. Current price divided by EPS is Rm 3.97 divided 7.99 = 49.6 P/E.
Conclusion:
Basing on production cost for 1 glove with market capitalization, Comfort is cheaper.
Basing on historical P/E ratio, Comfort is also cheaper.
A few day ago, Comfort shot up 30% to limit high with about 100 million shares traded. The average volume traded daily is about 70 million in the last few weeks. Only institutional investors have so much money to buy such big volume.
Nevertheless, Investor should consider Supermax’s advantages. Supermax is a larger company with its own brand and its own marketing organisation to sell its product, it should be able to sell its products at relatively higher prices with better margin of profit.
Currently my investment is 70% on Comfort and 30% on Supermax. I am not sure which has the better profit growth prospect in future.
Stock
2020-07-20 23:37 | Report Abuse
Comfort Gloves share price should fly relatively faster - Koon Yew Yin
Author: Koon Yew Yin | Publish date: Mon, 20 Apr 2020, 4:58 PM
Due to the Covid 19 pandemic the demand for rubber and nitrile gloves far exceeds supply. As a result, glove price continues to go up higher and higher and all glove manufacturers will benefit.
As you can see, all the glove manufacturers’ share prices have been going up recently. Based on historical earnings, Hartalega is selling at P/E about 60, Top Gloves is selling P/E 44, Supermax is selling at P/E above 20. Rubberex and Comfort are selling below 20.
Rubberex has a much larger new plant which was scheduled to start operation in June, but it is being delayed by MCO.
Comfort:
Comfort’s annual account closes in January 2020. Comfort has six new lines commenced operation in Feb 2020. This, alongside the existing 49 production lines in the two plants in Simpang and Matang, Taiping, are running at close to full capacity, which collectively can produce between 430-450m pieces of gloves/month. The commencement of the new lines was timely as it helps to cater for both existing demand as well as the global surge in demand – arising from the unexpected outbreak of the COVID-19 pandemic. Beyond current expansion, more capacity may be added in the future, as the company had acquired about 39 acres of land in Perak in 2018 that can potentially house more capacity ahead. As demand for nitrile and specialty gloves increase, the potential capacity expansion can help to capture more market share moving forward.
As I said, the additional manufacturing capacity since February is timely to take advantage of the higher glove prices. Its 1st quarter result ending April 2020 should be much better than its previous quarters.
Among all the glove manufacturers, Comfort has the best profit growth prospect which is the most powerful catalyst to move share price.
Stock
2020-07-20 23:37 | Report Abuse
Why Rubberex is flying faster than Comfort Gloves? Koon Yew Yin (Revised)
Author: Koon Yew Yin | Publish date: Mon, 4 May 2020, 2:38 PM
Covid 19 pandemic has been depressing all the major stock markets around the world. Our local stock market is not spared. To prevent Covid 19 infection, the demand for rubber and nitrile gloves exceeds supply. As a result, the glove prices have been going up higher and higher. All glove manufacturers’ profits are increasing and their share prices are also shooting up higher and higher.
Under such a situation, investors have the difficulty of selecting the company with the fastest profit growth rate to invest. Among all the share selection criteria such as NTA, cash flow, healthy accounts, EPS etc, I consider profit growth prospect is the most powerful catalyst to move share price.
Rubberex has the best profit growth prospect
Comfort Gloves
Currently Comfort is producing 450 million gloves per month or 5.4 billion gloves annually. From February it has added 6 new production lines to its existing 49 lines. The production increase is timely to take advantage of the higher sale prices.
Comfort has issued 580 million shares. Based on its current share price of Rm 1.55, its market capitalization is Rm 900 million.
Rubberex
Currently Rubberex is producing 1 billion gloves annually. Its new production plants which is scheduled to start operation in June has a production capacity of 2 billion gloves annually. The total production will be 3 billion gloves annually.
Rubberex has issued 252 million shares. Based on the its current share price of Rm 1.75, its market capitalisation is Rm 441 million.
Note: My intention for writing this piece is to help investors select wisely. I am obliged to inform you that I was a co-founder of Rubberex and I am not selling my holdings. I am not asking you to buy or sell. If you do, you are taking your own risk.
Note: I am sorry that I wrongly stated Comfort’s annual production was 450 million gloves. It should be 450 million per month and its annual production should be 5.4 billion gloves.
Stock
2020-07-20 23:35 | Report Abuse
Rubberex: Share placement is an acid test - Koon Yew Yin
Author: Koon Yew Yin | Publish date: Tue, 5 May 2020, 9:30 AM
Many investors would have seen the following announcement yesterday evening and wonder what to do. The question is: To sell or not to sell or to buy more shares?
On behalf of the the Board of Directors of Rubberex, RHB Investment Bank Berhad wishes to announce that Rubberex is proposing to undertake a proposed private placement of 25,219,500 new ordinary shares of Rubberex, representing approximately 10% of the total number of issued shares (excluding treasury shares) of Rubberex ("Proposed Private Placement").
This phrase “acid test” is derived from the test that the goldsmiths used during the 18th century to check the purity of gold. It was the test based on putting gold in nitric acid that dissolves every other metal except gold.
I use this phrase in the title of this article to provide definitive proof of whether the share placement is good or bad, effective or ineffective to the company and its shareholders.
As far as the company is concerned it is a good and easy way to secure cash from investors for production expansion which will eventually benefit all the shareholders. It is better and cheaper than borrowing money from the bank. According to listing rules, the company can give a maximum discount of 10% to the 5 day average price prior to the price fixing day. Shareholders would naturally feel that their interest is being diluted.
Fortunately or unfortunately, many ordinary investors would feel that they are being cheated because the price for the share placement is much cheaper than the current open market price, especially when the price shot up 28 sen and 19 sen in the last 2 trading days. Investors should be happy because the share price shot up so rapidly for a good reason.
The share price shot up so rapidly because the demand for gloves far exceeds supply due to Covid 19 pandemic. As a result, the selling price for gloves continues to go up- thus benefiting all the glove manufacturers and their shareholders.
The share price may drop initially because of share placement and also because it has shot up too rapidly. It should continue to go up higher and higher because it has very good profit growth prospect which is the most powerful catalyst to move up share price. Moreover, even with the placement shares its total issued shares is only 280 million shares while Comfort Gloves is 580 million shares.
Stock
Stock
Stock
2020-07-20 18:17 | Report Abuse
ATTENTION : To all Supermax Share Holders
Its seem that stockraider, TeamRocket,rr88 and greedy44444 already behave like a mad/crazy Dog
We should collaborate not to respond stockraider, TeamRocket,rr88 and greedy44444 comments
Just ignore and dont respond his comment
Treat his existence invisible or non existence at all
Especially the worst n pariah 1 rr88
Stock
Stock
Stock
Stock
Stock
2020-07-17 00:50 | Report Abuse
Who benefits the most if US ban TG products
The most beneficiary will be
1) Supermax OBM can sell higher price due to US in critical shortage of glove if TG is ban
2) Hartalega OEM
3) Kossan OEM
4) The rest of Malaysia smaller glove producer
Stock
2020-07-17 00:02 | Report Abuse
ATTENTION : To all Supermax Share Holders
Its seem that stockraider, TeamRocket,rr88 and greedy44444 already behave like a mad/crazy Dog
We should collaborate not to respond stockraider, TeamRocket,rr88 and greedy44444 comments
Just ignore and dont respond his comment
Treat his existence invisible or non existence at all
Especially the worst n pariah 1 stockraider
Stock
Stock
Stock
2020-07-16 23:37 | Report Abuse
ATTENTION : To all Supermax Share Holders
Its seem that stockraider, TeamRocket,rr88 and greedy44444 already behave like a mad/crazy Dog
We should collaborate not to respond stockraider, TeamRocket,rr88 and greedy44444 comments
Just ignore and dont respond his comment
Treat his existence invisible or non existence at all
Stock
2020-07-16 23:30 | Report Abuse
Who benefits the most if US ban TG products
The most beneficiary will be
1) Supermax OBM can sell higher price due to US in critical shortage of glove if TG is ban
2) Hartalega OEM
3) Kossan OEM
4) The rest of Malaysia smaller glove producer
Stock
Stock
Stock
2020-07-16 22:51 | Report Abuse
BRO me too bot at 14.6 50k lots
DJoker89 Nobody dare to collect today at 14.80
I think only me hahahahaha....
Show time continue tomorrow because today show been disrupted by TG news
Mark my words...;p
Stock
Stock
2020-07-16 22:47 | Report Abuse
ATTENTION : To all Supermax Share Holders
Its seem that TeamRocket,rr88 and greedy44444 already behave like a mad/crazy Dog
We should collaborate not to respond TeamRocket,rr88 and greedy44444 comments
Just ignore and dont respond his comment
Treat his existence invisible or non existence at all
Stock: [DPHARMA]: DUOPHARMA BIOTECH BERHAD
2020-07-23 19:48 |
Post removed.Why?